Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
von Minckwitz, Gunter, Schneeweiss, Andreas, Loibl, Sibylle, Salat, Christoph, Denkert, Carsten, Rezai, Mahdi, Blohmer, Jens U, Jackisch, Christian, Paepke, Stefan, Gerber, Bernd, Zahm, Dirk M, KümmelVolume:
15
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(14)70160-3
Date:
June, 2014
File:
PDF, 459 KB
english, 2014